These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 34378174)

  • 21. Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.
    Hommersom MP; Buijsen RAM; van Roon-Mom WMC; van de Warrenburg BPC; van Bokhoven H
    Stem Cell Rev Rep; 2022 Feb; 18(2):441-456. PubMed ID: 34031815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.
    Chen ML; Lin CC; Rosenthal LS; Opal P; Kuo SH
    J Neurol Sci; 2021 May; 424():117417. PubMed ID: 33836316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric-Like Impairments in Mouse Models of Spinocerebellar Ataxias.
    Tichanek F
    Cerebellum; 2023 Feb; 22(1):14-25. PubMed ID: 35000108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The preclinical stage of spinocerebellar ataxias.
    Maas RP; van Gaalen J; Klockgether T; van de Warrenburg BP
    Neurology; 2015 Jul; 85(1):96-103. PubMed ID: 26062625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
    Matilla-Dueñas A; Sánchez I; Corral-Juan M; Dávalos A; Alvarez R; Latorre P
    Cerebellum; 2010 Jun; 9(2):148-66. PubMed ID: 19890685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A New Mouse Model Related to SCA14 Carrying a Pseudosubstrate Domain Mutation in PKCγ Shows Perturbed Purkinje Cell Maturation and Ataxic Motor Behavior.
    Shimobayashi E; Kapfhammer JP
    J Neurosci; 2021 Mar; 41(9):2053-2068. PubMed ID: 33478986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Climbing fibers in spinocerebellar ataxia: A mechanism for the loss of motor control.
    Smeets CJ; Verbeek DS
    Neurobiol Dis; 2016 Apr; 88():96-106. PubMed ID: 26792399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical neurogenetics: autosomal dominant spinocerebellar ataxia.
    Shakkottai VG; Fogel BL
    Neurol Clin; 2013 Nov; 31(4):987-1007. PubMed ID: 24176420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keeping Our Calcium in Balance to Maintain Our Balance.
    Mark MD; Schwitalla JC; Groemmke M; Herlitze S
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1040-1050. PubMed ID: 27392710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterotopic Purkinje Cells: a Comparative Postmortem Study of Essential Tremor and Spinocerebellar Ataxias 1, 2, 3, and 6.
    Louis ED; Kuo SH; Tate WJ; Kelly GC; Gutierrez J; Cortes EP; Vonsattel JG; Faust PL
    Cerebellum; 2018 Apr; 17(2):104-110. PubMed ID: 28791574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
    Afonso-Reis R; Afonso IT; Nóbrega C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical diagnosis of autosomal dominant spinocerebellar ataxias.
    Klockgether T
    Cerebellum; 2008; 7(2):101-5. PubMed ID: 18418679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.
    Gómez-Ruiz M; Rodríguez-Cueto C; Luna-Piñel E; Hernández-Gálvez M; Fernández-Ruiz J
    Front Mol Neurosci; 2019; 12():94. PubMed ID: 31068788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain pathology of spinocerebellar ataxias.
    Seidel K; Siswanto S; Brunt ER; den Dunnen W; Korf HW; Rüb U
    Acta Neuropathol; 2012 Jul; 124(1):1-21. PubMed ID: 22684686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The spinocerebellar ataxias: clinical aspects and molecular genetics.
    Matilla-Dueñas A; Corral-Juan M; Volpini V; Sanchez I
    Adv Exp Med Biol; 2012; 724():351-74. PubMed ID: 22411256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
    Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
    Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinocerebellar ataxia: an update.
    Sullivan R; Yau WY; O'Connor E; Houlden H
    J Neurol; 2019 Feb; 266(2):533-544. PubMed ID: 30284037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The wide spectrum of spinocerebellar ataxias (SCAs).
    Manto MU
    Cerebellum; 2005; 4(1):2-6. PubMed ID: 15895552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays.
    Scott SSO; Pedroso JL; Barsottini OGP; França-Junior MC; Braga-Neto P
    J Neurol Sci; 2020 Oct; 417():117082. PubMed ID: 32791425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinocerebellar ataxia: relationship between phenotype and genotype - a review.
    Sun YM; Lu C; Wu ZY
    Clin Genet; 2016 Oct; 90(4):305-14. PubMed ID: 27220866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.